跳到正文
cccskills
免费在 GitHub 公开

endo-rtcgm-recommend-t1dm-above-target

Recommends real-time continuous glucose monitoring (RT-CGM) for adult patients with type 1 diabetes mellitus (T1DM) whose hemoglobin A1C is above individualized target. Consider when clinician notes 'T1DM A1C above goal, consider RT-CGM' or 'Patient willing to wear CGM daily, A1C elevated'.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL

实测评分 未实测

查看安装方法

包含的文件（1）

  • SKILL.md2.7 KB

SKILL.md（原文）

安装前可以查看交给 AI 代理的指令内容。

Recommend RT-CGM for T1DM with A1C above target

STEP 1 — Gather Information

Confirm adult T1DM diagnosis, obtain current A1C and individualized target A1C, assess patient willingness and ability to use RT-CGM device on a nearly daily basis, and review insurance coverage/cost.
Action: If data are complete, proceed to Step 2.

STEP 2 — Rule In / Rule Out

Is the patient an adult with T1DM and has A1C above target?

  • Yes: Proceed to Step 3.
  • No: Do not recommend RT-CGM; address glycemic control with other modalities and reassess at next visit.

STEP 3 — Classify or Stratify

Classify by willingness and ability to use RT-CGM nearly daily:

  • Willing and able: Proceed to Step 4.
  • Unwilling or unable: Identify barriers (e.g., cost, dexterity, psychosocial concerns) and consider alternatives such as intermittent CGM or intensified SMBG.

STEP 4 — Decide

If willing and able: Initiate RT-CGM with device-specific education, training, and calibration plan; schedule follow-up in 1–2 weeks to review data and adjust therapy.
If unwilling/unable: Address barriers, provide education on SMBG, and reassess willingness at subsequent visits.

Clinical Guardrails / Mimics / Pitfalls

Do not rely on RT-CGM as a sole replacement for SMBG calibration; ensure patients receive formal device training to prevent alarm fatigue and skin irritation; avoid initiating in patients unable to perform required calibrations without caregiver support; consider cost and insurance coverage prior to prescription; do not use RT-CGM in patients with hypoglycemia unawareness without structured hypoglycemia prevention strategies.

Concrete Clinical Example

A 34‑year‑old woman with T1DM has A1C 8.2% (target <7.0%). She reports willingness to wear a CGM sensor daily, has no financial barriers, and can perform fingerstick calibrations. Clinician recommends RT‑CGM initiation, arranges trainer-led education, and schedules a follow‑up visit in 2 weeks to download data and adjust insulin doses.

Source: Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2534

TODO: consider adding scripts/calc.py for the endo-rtcgm-recommend-t1dm-above-target calculator

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问，或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护，适用 Google 的隐私权政策和服务条款。

同一仓库的技能

780g-pump-adjustment

免费

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-acth-stim-test-interpretation

免费

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-adrenal-crisis-treatment

免费

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-ai-education

免费

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-lt4-monitoring

免费

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-cortisol-cutoff-ai-diagnosis

免费

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题